MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1111/1471-0528.70045

Медицинская библиотека · BJOG : an international journal of obstetrics and gynaecology · 2025

Maternal Myo-Inositol Intake and Congenital Heart Defects in Offspring: A Population-Based Case-Control Study.

Cen Ruiqi, Su L Joseph, Ying Jun, Orloff Mohammed S, Bolin Elijah H, Lou Xiangyang, Almli Lynn M, Botto Lorenzo D, Browne Marilyn L, Finnell Richard H, Jenkins Mary M, Nestoridi Eirini, Olshan Andrew F, Romitti Paul A, Shaw Gary M, Nembhard Wendy N, National Birth Defects Prevention Study

СтатьяПеревод в очереди

Аннотация

OBJECTIVE

To investigate associations between maternal periconceptional (three months prior through the third pregnancy month) myo-inositol intake and the odds of selected congenital heart defects in offspring.

DESIGN

A population-based case-control study using the National Birth Defects Prevention Study (NBDPS) database.

SETTING

United States.

POPULATION OR SAMPLE: Women with singleton live births without major birth defects (controls) and women with singleton live births, stillbirths, or terminations with selected nonsyndromic congenital heart defects (CHD; cases).

METHODS

Descriptive analyses, logistic regression models, ascertainment of myo-inositol intake from supplements and food using a shortened food frequency questionnaire and survey.

MAIN OUTCOME MEASURES: Odds of CHD.

RESULTS

11 752 cases and 11 415 controls were included. Compared to women not taking myo-inositol supplements, women with any supplemental intake were less likely to have a pregnancy with the selected congenital heart defects as a group (adjusted odds ratio [aOR] = 0.79; 95% confidence interval [CI] 0.66-0.94) or with septal defects alone (aOR = 0.61; 95% CI 0.46-0.81). Compared to women with low total myo-inositol intake from food or supplements, women with high total myo-inositol intake (≥ 500 mg/day) were less likely to have a pregnancy with the selected CHD as a group (aOR = 0.88; 95% CI 0.84-0.93) or conotruncal defects (aOR = 0.87; 95% CI 0.79-0.96); left ventricular outflow tract defects (aOR = 0.87; 95% CI 0.78-0.96); right ventricular outflow tract defects (aOR = 0.85; 95% CI 0.77-0.95); or atrial septal defects (aOR = 0.91; 95% CI 0.83-0.99).

CONCLUSIONS

An inverse association was observed between maternal myo-inositol intake during the periconceptional period and the odds of selected CHDs in offspring.

Для цитирования: Cen Ruiqi, Su L Joseph, Ying Jun, Orloff Mohammed S, Bolin Elijah H, Lou Xiangyang, Almli Lynn M, Botto Lorenzo D, Browne Marilyn L, Finnell Richard H, Jenkins Mary M, Nestoridi Eirini, Olshan Andrew F, Romitti Paul A, Shaw Gary M, Nembhard Wendy N, National Birth Defects Prevention Study. Maternal Myo-Inositol Intake and Congenital Heart Defects in Offspring: A Population-Based Case-Control Study.. BJOG : an international journal of obstetrics and gynaecology. 2025. DOI: 10.1111/1471-0528.70045.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.